Long term protection after hepatitis A and B vaccination: An update

Acta Gastro-Enterologica Belgica

Volumn 66, Issue 3, 2003, Pages 247-249

  Van Damme, Pierre ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Duration; Hepatitis A vaccine; Hepatitis B vaccine; Protection

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B VACCINE;

CONFERENCE PAPER; HEPATITIS A; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENCE; LONG TERM CARE; VACCINATION; VIRUS HEPATITIS;

HEPATITIS A; HEPATITIS B; HUMANS; TIME FACTORS; VACCINATION; VIRAL HEPATITIS VACCINES;

EID: 0142054992     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. European Consensus Group on Hepatitis B Immunity. Are booster immunisations needed for lifelong hepatitis B immunity? Lancet, 2000, 355: 561-565.
2. JILG W., SCHMIDT M., DEINHARDT F. Persistence of specific antibodies after hepatitis B vaccination. J. Hepatol., 1988, 6: 201-07.
3. BANATVALA J.E., VAN DAMME P. Hepatitis B vaccine - do we need boosters. J. Viral Hepatitis, 2003, 10: 1-6.
4. AYERBE M.C., PEREZ-RIVILLA A. & ICOVAHB GROUP. Assessment of long-term efficacy of hepatitis B vaccine. Eur. J. Epidemiol., 2001, 17: 151-156.
5. MANDEEP S. CHADHA, VIDYA A. ARANKALLA. Ten-year serological follow-up of hepatitis B vaccine recipients. Indian J. Gastroenterol., 2000, 19: 168-171.
6. WEST D.J., CALANDRA G.B. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine, 1996, 14: 1019-27.
7. BANATVALA J.E., VAN DAMME P., OEHEN S. Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. Vaccine, 2001, 19: 877-885.
8. BOLAND G.J., DE GAST G.C., ITALIANDER E., VAN DER REIJDEN J., VAN HATTUM L. Long term immunity to hepatitis B infection after vaccination with recombinant hepatitis B vaccine. Hepatology, 1995, 22: 325.
9. WISMANS P., VAN HATTUM J., DE GAST G.C. et al. A prospective study of in vitro anti-HBs producing B cells (spot-ELISA) following primary and supplementary vaccination with recombinant hepatitis B vaccine in insulin-dependent diabetic patients and matched controls. J. Med. Virol., 1991, 35: 216-22.
10. DENTICO P., CROVARI P., LAI P.L. et al. Anamnestic response to administration of purified non-adsorbed hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres. Vaccine, 2002, 20: 3725-3730.
11. VAN DAMME P., VAN HERCK K. Hepatitis A vaccination: more convenience for the traveller? 3rd European Conference on Travel Medicine, 2002, Florence, Italy, 15-18 May: Abstract 31.
12. VAN HERCK K., RENARD D., MOLENBERGHS G., VAN DAMME P. Model-based estimates of long-term persistence of vaccine induced hepatitis A antibodies. In: MARGOLIS H., ALTER M., LIANG T., DIENSTAG J. (eds.). Viral Hepatitis and Liver Diseases. Proceedings of the 10th International Symposium on Viral Hepatitis and Liver Diseases, April 9-13, 2000, Atlanta, USA: International Medical Press, Atlanta, USA, 2002: 56-9.
13. LANDRY P., TREMBLAY S., DARIOLI R., GENTON B. Inactivated hepatitis A vaccine booster given >/=24 months after the primary dose. Vaccine, 2000, 19: 399-402.
14. IWARSON S., LINDH M., WIDERSTROM L. Excellent booster response 4-6 y after a single primary dose of an inactivated hepatitis A vaccine. Scand. J. Infect. Dis., 2002, 34: 110-1.
15. PURCELL R.H., D'HONDT E., BRADBURY R., EMERSON S.U., GOVINDARAJAN S., BINN L. Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees. Vaccine, 1992, 10 Suppl 1: S148-51.
16. CHEN X. The immune response to hepatitis A vaccination: studies in vivo and in vitro: University Hospital Utrecht, 1996.
17. LEMON S.M. Immunologic approaches to assessing the response to inactivated hepatitis A vaccine. J. Hepatol., 1993, 18 Suppl 2: S15-9.
18. VAN DAMME P., LEROUX-ROELS G., LAW B. et al. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults. J. Med. Virol., 2001, 65: 6-13.